These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Grimsgaard S, Bonaa KH, Hansen JB, Nordøy A. Am J Clin Nutr; 1997 Sep; 66(3):649-59. PubMed ID: 9280188 [Abstract] [Full Text] [Related]
4. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ. Free Radic Biol Med; 2003 Oct 01; 35(7):772-81. PubMed ID: 14583341 [Abstract] [Full Text] [Related]
5. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ. Hypertension; 1999 Aug 01; 34(2):253-60. PubMed ID: 10454450 [Abstract] [Full Text] [Related]
6. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. Circulation; 2000 Sep 12; 102(11):1264-9. PubMed ID: 10982541 [Abstract] [Full Text] [Related]
7. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Leigh-Firbank EC, Minihane AM, Leake DS, Wright JW, Murphy MC, Griffin BA, Williams CM. Br J Nutr; 2002 May 12; 87(5):435-45. PubMed ID: 12010583 [Abstract] [Full Text] [Related]
9. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, Beilin LJ. Atherosclerosis; 2003 Jan 12; 166(1):85-93. PubMed ID: 12482554 [Abstract] [Full Text] [Related]
10. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Grimsgaard S, Bønaa KH, Hansen JB, Myhre ES. Am J Clin Nutr; 1998 Jul 12; 68(1):52-9. PubMed ID: 9665096 [Abstract] [Full Text] [Related]
11. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Toft I, Bønaa KH, Ingebretsen OC, Nordøy A, Jenssen T. Ann Intern Med; 1995 Dec 15; 123(12):911-8. PubMed ID: 7486485 [Abstract] [Full Text] [Related]
12. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U. J Nutr; 2009 May 15; 139(5):861-8. PubMed ID: 19261730 [Abstract] [Full Text] [Related]
13. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial. Asztalos IB, Gleason JA, Sever S, Gedik R, Asztalos BF, Horvath KV, Dansinger ML, Lamon-Fava S, Schaefer EJ. Metabolism; 2016 Nov 15; 65(11):1636-1645. PubMed ID: 27733252 [Abstract] [Full Text] [Related]
14. Docosahexaenoic acid reduces resting blood pressure but increases muscle sympathetic outflow compared with eicosapentaenoic acid in healthy men and women. Lee JB, Notay K, Klingel SL, Chabowski A, Mutch DM, Millar PJ. Am J Physiol Heart Circ Physiol; 2019 Apr 01; 316(4):H873-H881. PubMed ID: 30735073 [Abstract] [Full Text] [Related]
15. Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women. Ras RT, Demonty I, Zebregs YE, Quadt JF, Olsson J, Trautwein EA. J Nutr; 2014 Oct 01; 144(10):1564-70. PubMed ID: 25122648 [Abstract] [Full Text] [Related]
16. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Buckley R, Shewring B, Turner R, Yaqoob P, Minihane AM. Br J Nutr; 2004 Sep 01; 92(3):477-83. PubMed ID: 15469651 [Abstract] [Full Text] [Related]
17. Lipid, glycemic, and insulin responses to meals rich in saturated, cis-monounsaturated, and polyunsaturated (n-3 and n-6) fatty acids in subjects with type 2 diabetes. Shah M, Adams-Huet B, Brinkley L, Grundy SM, Garg A. Diabetes Care; 2007 Dec 01; 30(12):2993-8. PubMed ID: 17804680 [Abstract] [Full Text] [Related]
18. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study. Allaire J, Couture P, Leclerc M, Charest A, Marin J, Lépine MC, Talbot D, Tchernof A, Lamarche B. Am J Clin Nutr; 2016 Aug 01; 104(2):280-7. PubMed ID: 27281302 [Abstract] [Full Text] [Related]
19. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM. Nutr Res; 2009 Sep 01; 29(9):609-15. PubMed ID: 19854375 [Abstract] [Full Text] [Related]
20. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Stark KD, Holub BJ. Am J Clin Nutr; 2004 May 01; 79(5):765-73. PubMed ID: 15113713 [Abstract] [Full Text] [Related] Page: [Next] [New Search]